Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge.

1997 ◽  
Vol 71 (12) ◽  
pp. 9563-9569 ◽  
Author(s):  
C Schmaljohn ◽  
L Vanderzanden ◽  
M Bray ◽  
D Custer ◽  
B Meyer ◽  
...  
Vaccine ◽  
2003 ◽  
Vol 21 (25-26) ◽  
pp. 4071-4080 ◽  
Author(s):  
Jenny Riemenschneider ◽  
Aura Garrison ◽  
Joan Geisbert ◽  
Peter Jahrling ◽  
Michael Hevey ◽  
...  

2013 ◽  
Vol 9 (1) ◽  
pp. 66-82 ◽  
Author(s):  
Daniela Fioretti ◽  
Sandra Iurescia ◽  
Monica Rinaldi

Almost the entire territory of Belarus is believed to be endemic for tick-borne encephalitis virus (TBEV), with the Central European subtype, also known as TBEV-EU (Figure 1). In all, 96 counties (i.e., 71.5% of all administrative districts) are considered to be risk areas for tick-borne encephalitis (TBE). The most intensive natural foci have been found in the western part of the country (Brest and Grodno Area), and infections in these areas account for an average of 40% each of the total number of reported cases


2001 ◽  
Vol 75 (19) ◽  
pp. 9037-9043 ◽  
Author(s):  
Derek O'Hagan ◽  
Manmohan Singh ◽  
Mildred Ugozzoli ◽  
Carl Wild ◽  
Susan Barnett ◽  
...  

ABSTRACT The effectiveness of cationic microparticles with adsorbed DNA at inducing immune responses was investigated in mice, guinea pigs, and rhesus macaques. Plasmid DNA vaccines encoding human immunodeficiency virus (HIV) Gag and Env adsorbed onto the surface of cationic poly(lactide-coglycolide) (PLG) microparticles were shown to be substantially more potent than corresponding naked DNA vaccines. In mice immunized with HIV gag DNA, adsorption onto PLG increased CD8+ T-cell and antibody responses by ∼100- and ∼1,000-fold, respectively. In guinea pigs immunized with HIV env DNA adsorbed onto PLG, antibody responses showed a more rapid onset and achieved markedly higher enzyme-linked immunosorbent assay and neutralizing titers than in animals immunized with naked DNA. Further enhancement of antibody responses was observed in animals vaccinated with PLG/DNA microparticles formulated with aluminum phosphate. The magnitude of anti-Env antibody responses induced by PLG/DNA particles was equivalent to that induced by recombinant gp120 protein formulated with a strong adjuvant, MF-59. In guinea pigs immunized with a combination vaccine containing HIVenv and HIV gag DNA plasmids on PLG microparticles, substantially superior antibody responses were induced against both components, as measured by onset, duration, and titer. Furthermore, PLG formulation overcame an apparent hyporesponsiveness of the env DNA component in the combination vaccine. Finally, preliminary data in rhesus macaques demonstrated a substantial enhancement of immune responses afforded by PLG/DNA. Therefore, formulation of DNA vaccines by adsorption onto PLG microparticles is a powerful means of increasing vaccine potency.


Biomaterials ◽  
2009 ◽  
Vol 30 (30) ◽  
pp. 6017-6025 ◽  
Author(s):  
Han-Ning Huang ◽  
Tsung-Lin Li ◽  
Yi-Lin Chan ◽  
Chien-Lung Chen ◽  
Chang-Jer Wu

2018 ◽  
Vol 2018 ◽  
pp. 1-15 ◽  
Author(s):  
Lesley C. Dupuy ◽  
Michelle J. Richards ◽  
Brian D. Livingston ◽  
Drew Hannaman ◽  
Connie S. Schmaljohn

There remains a need for vaccines that can safely and effectively protect against the biological threat agents Venezuelan (VEEV), western (WEEV), and eastern (EEEV) equine encephalitis virus. Previously, we demonstrated that a VEEV DNA vaccine that was optimized for increased antigen expression and delivered by intramuscular (IM) electroporation (EP) elicited robust and durable virus-specific antibody responses in multiple animal species and provided complete protection against VEEV aerosol challenge in mice and nonhuman primates. Here, we performed a comparative evaluation of the immunogenicity and protective efficacy of individual optimized VEEV, WEEV, and EEEV DNA vaccines with that of a 1 : 1 : 1 mixture of these vaccines, which we have termed the 3-EEV DNA vaccine, when delivered by IM EP. The individual DNA vaccines and the 3-EEV DNA vaccine elicited robust and durable virus-specific antibody responses in mice and rabbits and completely protected mice from homologous VEEV, WEEV, and EEEV aerosol challenges. Taken together, the results from these studies demonstrate that the individual VEEV, WEEV, and EEEV DNA vaccines and the 3-EEV DNA vaccine delivered by IM EP provide an effective means of eliciting protection against lethal encephalitic alphavirus infections in a murine model and represent viable next-generation vaccine candidates that warrant further development.


npj Vaccines ◽  
2021 ◽  
Vol 6 (1) ◽  
Author(s):  
John J. Suschak ◽  
Joseph W. Golden ◽  
Collin J. Fitzpatrick ◽  
Charles J. Shoemaker ◽  
Catherine V. Badger ◽  
...  

AbstractCrimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne virus that causes severe hemorrhagic fever disease in humans. Currently, no licensed CCHF vaccines exist, and the protective epitopes remain unclear. Previously, we tested a DNA vaccine expressing the M-segment glycoprotein precursor gene of the laboratory CCHFV strain IbAr 10200 (CCHFV-M10200). CCHFV-M10200 provided >60% protection against homologous CCHFV-IbAr 10200 challenge in mice. Here, we report that increasing the dose of CCHFV-M10200 provides complete protection from homologous CCHFV challenge in mice, and significant (80%) protection from challenge with the clinically relevant heterologous strain CCHFV-Afg09-2990. We also report complete protection from CCHFV-Afg09-2990 challenge following vaccination with a CCHFV-Afg09-2990 M-segment DNA vaccine (CCHFV-MAfg09). Finally, we show that the non-structural M-segment protein, GP38, influences CCHF vaccine immunogenicity and provides significant protection from homologous CCHFV challenge. Our results demonstrate that M-segment DNA vaccines elicit protective CCHF immunity and further illustrate the immunorelevance of GP38.


Sign in / Sign up

Export Citation Format

Share Document